Products for Research Use Only
RegisterLogin

JNJ-26854165

CAT: 0026-2479-5Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0026-2479-5Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
A novel p53-activating tryptamine derivative that acts as a HDM2 (Human Double Minute-2) antagonist with potential antineoplastic activity. JNJ-26854165 inhibits the binding of the HDM2–p53 complex to the proteasome, blocking the degradation of p53. It displays potent anti-proliferative and apoptosis-inducing activity in a broad range of p53 wild type and mutant tumor models.
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
24 months

Related Products

CatalogName
B1072-5JNJ-42041935
9612-5JNJ-26481585
B1109-5JNJ-27018966
B2972-25JNJ-47965567
B1078-5JNJ-10198409
9612-25JNJ-26481585
B2974-5JNJ-17203212
B2063-25JNJ-38877605
2413-25JNJ-1661010
9648-25JNJ-31020028

Alternative Products

CatalogName
MBS384958-01JNJ 26854165
A10491-10JNJ 26854165 10mg
A4204-100JNJ-26854165 (Serdemetan)
C16160-100mgSerdemetan (JNJ-26854165)
A10491-50JNJ 26854165 50mg
A10491-25JNJ 26854165 25mg
A10491-5JNJ 26854165 5mg
A10491-2JNJ 26854165 2mg
A10491-500JNJ 26854165 500mg
A10491-100JNJ 26854165 100mg

Popular Products